Nebula Genomics

Nebula Genomics is a personal genomics company based in San Francisco, California. It offers a whole-genome sequencing service.[1][2]

Nebula Genomics
TypePrivate
IndustryBiotechnology
Personal Genomics
Founded2018
FounderGeorge Church
Dennis Grishin
Kamal Obbad
Headquarters
San Francisco, California
ServicesGenetic testing
Whole-genome sequencing
Websitewww.nebula.org

History

Nebula Genomics was co-founded in 2018 by George Church, geneticist at Harvard Medical School.[3][4] In August 2018, Nebula Genomics announced a seed funding round of $4.3 million led by Khosla Ventures.[5][6] In February 2020, Nebula Genomics began offering high-coverage whole-genome sequencing for $299 internationally.[7] The service also requires a subscription to Nebula Explore.[8] On 11 August 2021, ProPhase Labs, a diversified medical science and technology company, announced the acquisition of Nebula Genomics by its recently formed subsidiary, ProPhase Precision Medicine, Inc., for about $14.6 million in a combination of ProPhase Labs common stock and cash.[9]

Privacy concerns

Relationship with BGI Group
See also: BGI Group § Controversies

BGI Group is a Chinese life sciences company that has been part of many controversies, especially regarding genetic data. One of these concerns one of the most popular prenatal test in the world, Reuters found out that it has been developed with the involvement of Chinese's army, People's Liberation Army (PLA), and has been used to collect genetic data from millions of women.[10] George Church, the co-founder of Nebula Genomics, has served on the BGI Group's scientific advisory board since 2007. In 2017, BGI established the George Church Institute of Regenesis, a research collaboration between Church’s lab and about a dozen staffers at BGI in China. On 18 February 2020, Nebula Genomics has also announced that has partnered up with BGI: the saliva samples sent for decoding to Nebula Genomics are then sent by the company to BGI labs in Hong Kong for sequencing.[11] In 2022 Nebula Genomics stated in its FAQs that the samples are sequenced in Europe.[12] However, in 2023 no specific statement of sequencing location exists in the FAQs. Nebula Genomics said that this partnership is made to bring down the cost of whole-genome sequencing since normally it has a cost that makes it inaccessible to most people.[13]

Use by law enforcement and risk of data breaches

Nebula Genomics says that it is developing its own blockchain to enforce security and privacy but, despite that, re-identification of people starting from the genetic data could still be possible (DNA itself is a unique identifier), law enforcement could still issue search warrants or subpoena the data and this technology, given also the fact that is hard to implement, could still be vulnerable to data breaches.[14][15] This is also stated in Nebula Genomics' Privacy Policy: "However, under certain circumstances your genetic information may be subject to processing pursuant to laws, regulations or judicial or governmental orders, warrants or subpoenas. In other words, a lawful demand by public authorities may require we share your personal Information", they also state that: "We may share your personal data if we believe it is reasonably necessary to enforce the Nebula Terms and Conditions, protect the security and integrity of our Services, or protect the rights, safety, or property of Nebula, our employees or users". About data breaches risk it's written that: "While we cannot guarantee that loss, access or misuse of data will not occur, we use reasonable efforts to prevent these outcomes."[16]

Technology

Nebula Genomics develops technologies to enable controllable, transparent and secure genomic data sharing.[17] It is also developing approaches for privacy-preserving analysis of genomic datasets.[18][19]

Awards

In 2019, Nebula Genomics won the “Best-in-Show” award at the SXSW Pitch competition, part of the South by Southwest festival.[20]

Controversy

In 2023 it came to light that even though Nebula Genomics claims to decode 100% of the genome, this is actually not correct. While they sequence 100%, it appears to be the norm that less than 100% is decoded, due to some DNA not being able to be read. Nebula Genomics claims that this is just in the noncoding portion of the genome, however this noncoding portion (which makes up over 99% of the entire genome) plays a role in controlling gene activity.[21]

References
  1. "Startup Offers To Sequence Your Genome Free Of Charge, Then Let You Profit From It". NPR.org. Retrieved 2020-03-15.
  2. Purdy, Chase (16 November 2018). "Everyday people can now map their genomes and maybe keep their privacy". Quartz. Retrieved 2020-03-15.
  3. Mullin, Emily. "This new company wants to sequence your genome and let you share it on a blockchain". MIT Technology Review. Retrieved 2020-03-15.
  4. "In startup, George Church bets cryptocurrency will boost DNA sequencing". STAT. 2018-02-07. Retrieved 2020-03-15.
  5. "George Church's genetics on the blockchain startup just raised $4.3 million from Khosla". TechCrunch. 29 August 2018. Retrieved 2020-03-14.
  6. "Nebula Genomics Raises $4.3M, Partners With Veritas". GenomeWeb. 29 August 2018. Retrieved 2020-03-15.
  7. Mullin, Emily (2020-02-20). "The Price of DNA Sequencing Dropped From $2.7 Billion to $300 in Less Than 20 Years". Medium. Retrieved 2020-03-14.
  8. "The Price of DNA Sequencing". Retrieved 2020-10-14.
  9. "ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics". Benzinga. 2021-08-11. Archived from the original on 2022-02-18. Retrieved 2022-02-18.
  10. Needham, Kirsty; Baldwin, Clare (7 July 2021). "China's gene giant harvests data from millions of women". Reuters. Archived from the original on 10 July 2021. Retrieved 2022-02-14.
  11. Whalen, Jeanne; Dwoskin, Elizabeth (2020-07-02). "California rejected Chinese company's push to help with coronavirus testing. Was that the right move?". Washington Post. Archived from the original on 2022-02-14. Retrieved 2022-02-14.
  12. "FAQs". Nebula Genomics. Archived from the original on 2022-05-23. Retrieved 2022-05-23. Where will my sample be sequenced? We sequence our samples in a laboratory in the European Union (EU).
  13. "Nebula Genomics, Partnering with BGI, Sets Industry Standard by Offering 30x Whole-Genome Sequencing for $299". BioSpace. 2020-02-18. Archived from the original on 2022-01-18. Retrieved 2022-02-14.
  14. Weintraub, Karen (2018-11-17). "Genetics Start-Up Wants to Sequence People's Genomes for Free". Scientific American. Archived from the original on 2021-03-03. Retrieved 2022-02-14.
  15. Molteni, Megan (2019-09-19). "You Can Soon Get Your DNA Sequenced Anonymously". Wired. Archived from the original on 2022-02-14. Retrieved 2022-02-14.
  16. Quinn, Kevin (2019-11-21). "Privacy Policy". Nebula Genomics. Archived from the original on 2020-12-03. Retrieved 2022-02-14.
  17. Grishin, Dennis; Obbad, Kamal; Church, George M. (2019). "Data privacy in the age of personal genomics". Nature Biotechnology. 37 (10): 1115–1117. doi:10.1038/s41587-019-0271-3. ISSN 1546-1696. PMID 31537915. S2CID 202687125.
  18. Grishin, Dennis; Raisaro, Jean Louis; Troncoso-Pastoriza, Juan Ramón; Obbad, Kamal; Quinn, Kevin; Misbach, Mickaël; Gollhardt, Jared; Sa, Joao; Fellay, Jacques; Church, George M.; Hubaux, Jean-Pierre (2019-10-10). "Citizen-Centered, Auditable, and Privacy-Preserving Population Genomics". bioRxiv: 799999. doi:10.1101/799999.
  19. "This Company Wants to Sequence Your Genome, Put It On a Blockchain—And Pay You For It". Fortune. Retrieved 2020-03-15.
  20. "The Funded: Two Bay Area startups win SXSW Pitch competition". www.bizjournals.com. Retrieved 2020-03-14.
  21. "What is noncoding DNA?". Retrieved 2023-05-25.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.